AbCellera Biologics Inc. <ABCL.O>: Truist Securities raises target price to $30 from $12
ABCL•Related News
Revvity to present at Wells Fargo annual healthcare investor conference
RVTY•
908 Devices forecasts 2026 revenue from continuing operations of $68 million to $70 million
MASS•
Oil pares gains as traders weigh Oman-Iran talks
XLE•
Organigram Q3 FY2026 net revenue rises 49% to CAD 105.78 million, driven by Sanity Group contribution, company says
OGI•
JPM assumes Take-Two with 'overweight' on boost from planned GTA VI release
TTWO•